DK0762877T3 - Meta-substituerede arylalkylaminer og terapeutiske og diagnostiske anvendelser deraf - Google Patents

Meta-substituerede arylalkylaminer og terapeutiske og diagnostiske anvendelser deraf

Info

Publication number
DK0762877T3
DK0762877T3 DK95922166T DK95922166T DK0762877T3 DK 0762877 T3 DK0762877 T3 DK 0762877T3 DK 95922166 T DK95922166 T DK 95922166T DK 95922166 T DK95922166 T DK 95922166T DK 0762877 T3 DK0762877 T3 DK 0762877T3
Authority
DK
Denmark
Prior art keywords
meta
therapeutic
diagnostic uses
substituted arylalkylamines
compounds
Prior art date
Application number
DK95922166T
Other languages
Danish (da)
English (en)
Inventor
David R Elmaleh
Allan J Fischman
Original Assignee
Thejmde Trust
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/265,512 external-priority patent/US6004990A/en
Application filed by Thejmde Trust filed Critical Thejmde Trust
Application granted granted Critical
Publication of DK0762877T3 publication Critical patent/DK0762877T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/30—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by two rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Indole Compounds (AREA)
DK95922166T 1994-06-03 1995-06-02 Meta-substituerede arylalkylaminer og terapeutiske og diagnostiske anvendelser deraf DK0762877T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25403294A 1994-06-03 1994-06-03
US08/265,512 US6004990A (en) 1994-06-03 1994-06-24 Meta substituted arylalkylamines and therapeutic and diagnostic uses therefor
PCT/US1995/006950 WO1995033455A1 (fr) 1994-06-03 1995-06-02 Arylalkylamines meta substituees et utilisations therapeutiques et diagnostiques de celles-ci

Publications (1)

Publication Number Publication Date
DK0762877T3 true DK0762877T3 (da) 2001-07-16

Family

ID=26943786

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95922166T DK0762877T3 (da) 1994-06-03 1995-06-02 Meta-substituerede arylalkylaminer og terapeutiske og diagnostiske anvendelser deraf

Country Status (12)

Country Link
US (2) US5587398A (fr)
EP (1) EP0762877B1 (fr)
JP (1) JP3839049B2 (fr)
AT (1) ATE199829T1 (fr)
AU (1) AU707142B2 (fr)
CA (1) CA2191996A1 (fr)
DE (1) DE69520430T2 (fr)
DK (1) DK0762877T3 (fr)
ES (1) ES2157330T3 (fr)
GR (1) GR3036072T3 (fr)
PT (1) PT762877E (fr)
WO (1) WO1995033455A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
IL138342A0 (en) * 1998-03-17 2001-10-31 Pfizer Prod Inc Bicyclo[2.2.1] heptanes and related compounds
US6245782B1 (en) 1999-05-17 2001-06-12 Heartdrug Research L.L.C. Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
AU2003225277A1 (en) * 2002-05-02 2003-11-17 Robert Harris Lipid removal from the body
EP2250153B1 (fr) * 2008-01-18 2013-06-19 Allergan, Inc. Composes aryl-(imidazole)-methyl)-phenyle substitues servant de modulateurs selectifs des sous-types des recepteurs adrenergiques alpha 2b et/ou alpha 2c
US9549909B2 (en) 2013-05-03 2017-01-24 The Katholieke Universiteit Leuven Method for the treatment of dravet syndrome
BR112017006219A8 (pt) 2014-09-29 2023-02-14 Zogenix International Ltd Sistema de controle para controle de distribuição de medicamentos
EP3170807B1 (fr) 2015-11-23 2019-12-11 Frau Pharma S.r.l. Nouveau procédé de synthèse de la fenfluramine
US10689324B2 (en) 2015-12-22 2020-06-23 Zogenix International Limited Metabolism resistant fenfluramine analogs and methods of using the same
DK3800177T3 (da) * 2015-12-22 2025-03-31 Zogenix International Ltd Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme
RU2021106383A (ru) 2016-08-24 2021-04-05 Зодженикс Интернэшнл Лимитед Состав для ингибирования образования агонистов 5-ht2b и способы его применения
US10682317B2 (en) 2017-09-26 2020-06-16 Zogenix International Limited Ketogenic diet compatible fenfluramine formulation
CA3097335A1 (fr) 2018-05-11 2019-11-14 Zogenix International Limited Compositions et methodes pour traiter la mort subite provoquee par la crise epileptique
BR112021001135A2 (pt) * 2018-07-27 2021-04-20 Xenon Pharmaceuticals Inc. compostos e composições farmacêuticas para tratar epilepsia ou transtorno convulsivo epiléptico
WO2020105005A1 (fr) 2018-11-19 2020-05-28 Zogenix International Limited Méthodes de traitement du syndrome de rett à l'aide de fenfluramine
US11612574B2 (en) 2020-07-17 2023-03-28 Zogenix International Limited Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6626M (fr) * 1967-09-22 1969-01-13
DE1802297C3 (de) * 1967-10-25 1974-10-17 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt, Budapest Isopropylaminderivate und Verfahren zu ihrer Herstellung
US3573304A (en) * 1968-12-03 1971-03-30 Delalande Sa 1-dimethylamino - 3 - methyl-2(pyridyl or pyridazinyl) pentane and the corresponding non-toxic acid addition salts thereof
US3856857A (en) * 1970-02-13 1974-12-24 En Nom Collectif Science Union Amino acids and their derivatives
US3733339A (en) * 1970-10-05 1973-05-15 Abbott Lab Disubstituted propionamides
USB787097I5 (fr) * 1971-06-04
BE791772A (fr) * 1971-06-11 1973-03-16 Buzas Andre Derives d'acides phenoxy-acetiques, leur preparation et leur application en therapeutique
BE795041A (fr) * 1972-02-07 1973-08-06 Science Union & Cie Nouveaux derives de l'amino-propane
GB1434088A (en) * 1973-08-16 1976-04-28 Science Union & Cie N-substituted glycinates a process for their preparation and pharmaceutical compositions containing them
US4025624A (en) * 1975-11-18 1977-05-24 A. H. Robins Company, Incorporated Phenylalkylamines and phenylalkylureas in combinations to suppress gastric bleeding in aspirin therapy
US4115587A (en) * 1976-02-04 1978-09-19 A. H. Robins Company, Inc. Fatty acid amides of norfenfluramine and compositions and methods thereof
US4237165A (en) * 1976-06-04 1980-12-02 Science Union Et Cie Treatment of carbohydrate metabolism disorders
FR2508442A1 (fr) * 1981-06-30 1982-12-31 Sanofi Sa Procede de preparation d'ethylamines b-cyclo-substituees et produits ainsi obtenus
HU207282B (en) * 1984-05-31 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing phenyl-alkyl-amine derivatives and pharmaceutical compositions containing them
HU197510B (en) * 1986-12-19 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick
US4857553A (en) * 1987-08-06 1989-08-15 A. H. Robins Company, Incorporated Method of treating nausea and vomiting with certain substituted-phenylalkylamino (and aminoacid) derivatives and other serotonin depleting agents
JP2938463B2 (ja) * 1987-10-22 1999-08-23 マサチユセツツ・インスチチユート・オブ・テクノロジー 月経前又は後期黄体期症候群の処置
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
US4999382A (en) * 1988-10-26 1991-03-12 Massachusetts Institute Of Technology Compositions for treating tobacco withdrawal symptoms and methods for their use
GB9011767D0 (en) * 1990-05-25 1990-07-18 Britannia Pharmaceuticals Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
JP3839049B2 (ja) 2006-11-01
ES2157330T3 (es) 2001-08-16
CA2191996A1 (fr) 1995-12-14
DE69520430D1 (de) 2001-04-26
US6313175B1 (en) 2001-11-06
EP0762877B1 (fr) 2001-03-21
DE69520430T2 (de) 2001-10-18
HK1014671A1 (en) 1999-09-30
US5587398A (en) 1996-12-24
GR3036072T3 (en) 2001-09-28
AU2695095A (en) 1996-01-04
JPH10501239A (ja) 1998-02-03
AU707142B2 (en) 1999-07-01
WO1995033455A1 (fr) 1995-12-14
EP0762877A1 (fr) 1997-03-19
PT762877E (pt) 2001-08-30
ATE199829T1 (de) 2001-04-15

Similar Documents

Publication Publication Date Title
ATE199829T1 (de) Meta substituierte arylalkylamine und therapeutische und diagnostische verwendung davon
GEP20074197B (en) 5ht2c receptor modulators
BR0012793A (pt) Métodos para indução de angiogênese pela administração de nicotina ou outro agonista de receptor de nicotina
DE69840909D1 (de) Analoge von kokain
BR0208957A (pt) Ciclobuteno-1,2-dionas 3,4-dissubstituìdas como ligandos de receptor de quimiocina cxc
BR0309875A (pt) métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto
BRPI0407001A (pt) Método para aumentar a estabilidade de uma proteìna purificada, uso de uma proteìna ligante sìtio-especìfica ativa, método para aumentar a produção de uma proteìna recombinante e composição farmacêutica
MY140187A (en) Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
MY132626A (en) CARBAZOLYL-SUBSTITUTED ETHANOLAMINES AS SELECTIVE ß-3 AGONISTS
BR9917038A (pt) Composto, composição farmacêutica, método de modulação da atividade receptora de quimocinas, método de tratamento ou prevenção de doenças inflamatórias, método de tratamento ou prevenção de asma e método de tratamento ou prevenção de disfunções inflamatórias
DK0616812T3 (da) Kombination af antihormonforbindelser og bindingsmolekyler til behandling af cancer
BR0210711A (pt) Uso de um composto, composição farmacêutica, composto, e, processo para a preparação de um composto
EA200600041A1 (ru) Применение изомальта (смеси 1,6-gps и 1,1-gpm) в качестве пребиотика, в частности, для получения лекарственного средства для лечения кишечных заболеваний
NO20003550D0 (no) Farmasøytiske sammensetninger og anvendelse herav
MY139541A (en) Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
DK0412149T3 (da) Anvendelse af IL-7 til tilvejebringelse af lægemidler til stimulering af blodpladeproduktion
BRPI0409914A (pt) ácidos carboxìlicos substituìdos
EP0797999A3 (fr) Formulations de protéine d'obésité
EP1543158A4 (fr) Compositions th rapeutiques aptam riques r gul es
NO933960L (no) Interleukinreseptor-maalsoekende molekyler for behandling av inflam matorisk artritis
BR0112807A (pt) Derivados de indol e sua aplicação como medicamento
ES2144054T3 (es) Complejos de tri(platino).
BG101605A (bg) Ентерокинетични бензамиди
BG102707A (bg) Нови триазолопурини, метод за тяхното получаване и тяхното приложение като лекарствени средства
MXPA02000680A (es) Polipeptidos vgf y metodos para tratar desordenes relacionados con vgf.